MORRISVILLE, N.C.--(BUSINESS WIRE)--Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (Nasdaq:BDSI), will present at the Oppenheimer Pain Conference Tuesday, March 6, 2007 at the Flatotel Hotel in New York. Dr. Sirgo will participate in a panel discussion on “New Treatments in Breakthrough Pain” beginning at 11:00 AM ET, to discuss the potential benefits of BDSI’s Phase III BEMA™ Fentanyl product for the treatment of breakthrough cancer pain.
